세계의 남성용 생식 의료기기 시장 : 규모, 점유율, 동향 분석(2025-2031년) - MedCore
Men´s Reproductive Health Market Size, Share & Trend Analysis | Global | 2025-2031 | MedCore | Includes: Inflatable and Malleable Erectile Dysfunction Device Markets
상품코드:1667642
리서치사:iData Research Inc.
발행일:2024년 12월
페이지 정보:영문 47 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 남성용 생식 의료기기 시장 규모는 2024년에 2억 8,900만 달러 이상에 달했습니다. 이 시장은 2.5%의 CAGR로 확대하며, 2031년에는 3억 4,300만 달러 이상에 달할 것으로 예측됩니다.
전립선 비대증(BPH) 및 전립선암 치료와의 관련성이 높은 시장입니다. 방사선 치료로 인한 ED는 근치적 전립선 절제술(RP)에 비해 발병 시기가 늦어지는 경향이 있습니다. 팽창식 및 가단성 음경 보철물에 대한 기술 혁신이 증가하고 있습니다.
세계의 남성용 생식 의료기기 시장에 대해 조사했으며, 시장의 개요와 부문별, 지역별 동향, 경쟁 구도 등을 제공하고 있습니다.
목차
남성용 생식 의료기기 시장
개요
서론
시술 건수
발기부전 관리 시술
시장 개요
부문별
지역별
시장 분석과 예측
남성 생식 의료기기 시장 전체
팽창식 발기부전 치료 기기 시장
가단성 발기부전 치료 기기 시장
촉진요인과 억제요인
경쟁 시장 점유율 분석
KSA
영문 목차
영문목차
The global men's reproductive health device market was valued at over $289 million in 2024 and is projected to grow at a CAGR of 2.5%, reaching over $343 million by 2031.
Market Segments Covered:
Inflatable Erectile Dysfunction (ED) Devices
Malleable Erectile Dysfunction Devices
Comprehensive Market Insights
Market Size & Growth Trends
Unit Sales & Average Selling Prices
Market Drivers & Limiters
Procedure Numbers
Forecasts Until 2031 & Historical Data (2021-2023)
Competitive Market Share Insights
Recent Mergers & Acquisitions
Company Profiles & Product Portfolios
Global Market Trends
Erectile Dysfunction Prevalence: Strongly linked to Benign Prostatic Hyperplasia (BPH) and prostate cancer treatments.
Treatment Patterns: ED caused by radiation therapy tends to develop later compared to radical prostatectomy (RP).
Technological Advancements: Increasing innovation in inflatable and malleable penile prostheses.
Market Share Insights
Top Competitors in the Global Erectile Dysfunction Device Market (2024):
1 Boston Scientific
* Market leader offering the AMS 700(TM) MS Series (three-piece inflatable devices) and AMS Ambicor(R) (two-piece inflatable devices).
* Dominates the market following its 2018 acquisition of American Medical Systems (AMS).
2 Coloplast
* Second-largest competitor with the Titan(R) Inflatable Penile Prosthesis and Malleable Penile Prostheses.
3 Rigicon
* Newest entrant offering the Rigi10(TM) (malleable prosthesis) and Infla10(R) (inflatable prosthesis).
Market Segmentation Summary
Inflatable Erectile Dysfunction Devices
Malleable Erectile Dysfunction Devices
Global Research Scope
Report Details:
Regions Covered:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage:
Market Size, Market Shares, Market Growth Rates
Unit Sales & Average Selling Prices
Qualitative Coverage:
COVID-19 Impact
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Disruptive Technologies
Disease Overviews
Data Sources:
Primary Interviews with Industry Leaders
Government & Regulatory Data
Hospital & Private Sector Data
Import & Export Records
iData Research Internal Database
TABLE OF CONTENT
Table of Contents
Men's reproductive health Device Market
12.1 Executive Summary
12.1.1 Global Erectile Dysfunction Device Market Overview
12.1.2 Competitive Analysis
12.1.3 Market Segmentation
12.1.4 Regions Included
12.2 Introduction
12.3 Procedure Numbers
12.3.1 Erectile Dysfunction Management Procedures
12.3.1.1 Inflatable Implant Procedures
12.3.1.2 Malleable Implant Procedures
12.4 Market Overview
12.4.1 By Segment
12.4.2 By Region
12.5 Market Analysis and Forecast
12.5.1 Total Men's Reproductive Health Device Market
